Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.
Researchers developed and validated a sequencing method for mRNA vaccines, moving the manufacturing field forward by linking established technologies with translational applications.
In this webinar, Elena Piskounova and Christina Towers discuss the implications of metabolic changes in cancer cells for therapeutic development and efficacy.